ExeVir Bio secures funding for COVID program
ExeVir Bio, a Belgian biotech company developing nanobody therapies for broad protection against infectious diseases,…
January 9, 2023 - 3 minutes
ExeVir Bio, a Belgian biotech company developing nanobody therapies for broad protection against infectious diseases,…